Chronic graft-versus-host disease

Stephanie J. Lee, Georgia Vogelsang, Mary E.D. Flowers

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.

Original languageEnglish (US)
Pages (from-to)215-233
Number of pages19
JournalBiology of Blood and Marrow Transplantation
Volume9
Issue number4
DOIs
StatePublished - Apr 2003

Keywords

  • Allogeneic stem cell transplantation
  • Chronic graft-versus-host disease

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Chronic graft-versus-host disease'. Together they form a unique fingerprint.

Cite this